Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

Leflunomide can cause skin ulcers, and stopping it can lead to healing.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Hair loss can be an early sign of Crohn's disease in children.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Anti-TNF therapy can cause hair loss and skin issues.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Near-infrared laser therapy with Indocyanine Green dye improves acne by reducing inflammation without side effects.

A woman recovered from hair loss and skin eruptions after stopping a tuberculosis drug and using steroids.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Microvascular damage and platelet issues persist in ulcerative colitis remission, helping assess disease states.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Crohn's disease can cause hair loss before other symptoms appear.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

Quadruple-coated probiotics significantly improve IBS symptoms.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

IL-1 blockade is effective for treating SURF, and personalized treatment is needed.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.